Open AccessIn vitro antistaphylococcal activity of dalbavancin, a novel glycopeptide
Author(s) -
Sara Lopez,
C J Hackbarth,
Gabriella Romanò,
Joaquim Trias,
Daniela Jabés,
Beth P. Goldstein
Publication year - 2005
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dki007
Subject(s) - dalbavancin , teicoplanin , glycopeptide , microbiology and biotechnology , vancomycin , staphylococcus aureus , glycopeptide antibiotic , antibiotics , in vitro , chemistry , biology , bacteria , biochemistry , genetics
Dalbavancin is a novel, semi-synthetic glycopeptide antibiotic. The aim of this study was to further explore its activity against staphylococci.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom